M
10b5-1 Plan
$ Value
$172K
Shares
7,958
Price
$22
Filed
Apr 3
Insider
Name
Sloan Sheldon
Title
Chief Medical Officer
CIK
0002038798
Roles
Officer
Transaction Details
Transaction Date
2026-04-01
Code
M
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
7,958
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on June 20, 2025. | This option represents a right to purchase 95,500 shares of the Issuer's common stock, which will vest in equal monthly installments over four years, subject to the Reporting Person's continued employment with the Issuer at each vesting date.
Filing Info
Sloan Sheldon's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | SYRE | M | $172K |
| 2026-04-01 | SYRE | ▼ | $398K |
| 2026-04-01 | SYRE | M | $0 |
Other Insiders at SYRE (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Turtle Cameron
Chief Executive Officer
|
— | $740K | 2026-04-01 |
|
Burrows Scott L
Chief Financial Officer
|
— | $370K | 2026-04-01 |
|
Sloan Sheldon
Chief Medical Officer
|
— | $398K | 2026-04-01 |